Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 192

1.

Use of simple pharmacokinetic modeling to characterize exposure of Australians to perfluorooctanoic acid and perfluorooctane sulfonic acid.

Thompson J, Lorber M, Toms LM, Kato K, Calafat AM, Mueller JF.

Environ Int. 2010 May;36(4):390-7. doi: 10.1016/j.envint.2010.02.008. Epub 2010 Mar 16. Erratum in: Environ Int. 2010 Aug;36(6):647-8.

PMID:
20236705
2.
3.

Background levels of persistent organic pollutants in humans from Taiwan: perfluorooctane sulfonate and perfluorooctanoic acid.

Hsu JY, Hsu JF, Ho HH, Chiang CF, Liao PC.

Chemosphere. 2013 Sep;93(3):532-7. doi: 10.1016/j.chemosphere.2013.06.047. Epub 2013 Jul 22.

PMID:
23886440
4.

[Comparison of perfluorooctane sulfonate and perfluorooctane acid in serum of non-occupational human from Shenyang and Chongqing areas].

Jin YH, Dong GH, Shu WQ, Ding M, Zhai C, Wang L, Liu X, Saitou N, Sasaki K.

Wei Sheng Yan Jiu. 2006 Sep;35(5):560-3. Chinese.

PMID:
17086703
5.

The influence of time, sex and geographic factors on levels of perfluorooctane sulfonate and perfluorooctanoate in human serum over the last 25 years.

Harada K, Saito N, Inoue K, Yoshinaga T, Watanabe T, Sasaki S, Kamiyama S, Koizumi A.

J Occup Health. 2004 Mar;46(2):141-7.

6.

Estimating consumer exposure to PFOS and PFOA.

Trudel D, Horowitz L, Wormuth M, Scheringer M, Cousins IT, Hungerbühler K.

Risk Anal. 2008 Apr;28(2):251-69. doi: 10.1111/j.1539-6924.2008.01017.x. Erratum in: Risk Anal. 2008 Jun;28(3):807.

PMID:
18419647
7.

Perfluorinated compounds in human blood, water, edible freshwater fish, and seafood in China: daily intake and regional differences in human exposures.

Zhang T, Sun H, Lin Y, Wang L, Zhang X, Liu Y, Geng X, Zhao L, Li F, Kannan K.

J Agric Food Chem. 2011 Oct 26;59(20):11168-76. doi: 10.1021/jf2007216. Epub 2011 Sep 29.

PMID:
21928843
8.

Tissue bioaccumulation patterns, xenobiotic biotransformation and steroid hormone levels in Atlantic salmon (Salmo salar) fed a diet containing perfluoroactane sulfonic or perfluorooctane carboxylic acids.

Mortensen AS, Letcher RJ, Cangialosi MV, Chu S, Arukwe A.

Chemosphere. 2011 May;83(8):1035-44. doi: 10.1016/j.chemosphere.2011.01.067. Epub 2011 Feb 26.

PMID:
21354591
9.

Exposure and effective dose biomarkers for perfluorooctane sulfonic acid (PFOS) and perfluorooctanoic acid (PFOA) in infertile subjects: preliminary results of the PREVIENI project.

La Rocca C, Alessi E, Bergamasco B, Caserta D, Ciardo F, Fanello E, Focardi S, Guerranti C, Stecca L, Moscarini M, Perra G, Tait S, Zaghi C, Mantovani A.

Int J Hyg Environ Health. 2012 Feb;215(2):206-11. doi: 10.1016/j.ijheh.2011.10.016. Epub 2011 Dec 23.

PMID:
22197512
10.

Association between serum perfluorooctanoic acid (PFOA) and thyroid disease in the U.S. National Health and Nutrition Examination Survey.

Melzer D, Rice N, Depledge MH, Henley WE, Galloway TS.

Environ Health Perspect. 2010 May;118(5):686-92. doi: 10.1289/ehp.0901584. Epub 2010 Jan 7.

11.

Effects of age, gender and region on serum concentrations of perfluorinated compounds in general population of Henan, China.

Fu Y, Wang T, Wang P, Fu Q, Lu Y.

Chemosphere. 2014 Sep;110:104-10. doi: 10.1016/j.chemosphere.2014.02.020. Epub 2014 Mar 13.

PMID:
24630253
12.

Decline in perfluorooctane sulfonate and perfluorooctanoate serum concentrations in an Australian population from 2002 to 2011.

Toms LM, Thompson J, Rotander A, Hobson P, Calafat AM, Kato K, Ye X, Broomhall S, Harden F, Mueller JF.

Environ Int. 2014 Oct;71:74-80. doi: 10.1016/j.envint.2014.05.019. Epub 2014 Jun 27.

13.

The effect of ongoing blood loss on human serum concentrations of perfluorinated acids.

Lorber M, Eaglesham GE, Hobson P, Toms LM, Mueller JF, Thompson JS.

Chemosphere. 2015 Jan;118:170-7. doi: 10.1016/j.chemosphere.2014.07.093. Epub 2014 Sep 1.

PMID:
25180653
14.

Pilot study on the perfluorooctanesulfonate and perfluorooctanoate exposure of the German general population.

Midasch O, Schettgen T, Angerer J.

Int J Hyg Environ Health. 2006 Nov;209(6):489-96. Epub 2006 Jul 26.

PMID:
16872899
15.

Perfluorooctanesulfonate and perfluorooctanoic acid exposures of the Italian general population.

Ingelido AM, Marra V, Abballe A, Valentini S, Iacovella N, Barbieri P, Porpora MG, Domenico Ad, De Felip E.

Chemosphere. 2010 Aug;80(10):1125-30. doi: 10.1016/j.chemosphere.2010.06.025. Epub 2010 Jul 14.

PMID:
20633921
16.

Hazard quotient profiles used as a risk assessment tool for PFOS and PFOA serum levels in three distinctive European populations.

Ludwicki JK, Góralczyk K, Struciński P, Wojtyniak B, Rabczenko D, Toft G, Lindh CH, Jönsson BA, Lenters V, Heederik D, Czaja K, Hernik A, Pedersen HS, Zvyezday V, Bonde JP.

Environ Int. 2015 Jan;74:112-8. doi: 10.1016/j.envint.2014.10.001. Epub 2014 Oct 21.

PMID:
25454227
17.

Perfluoroalkyl acids in children and their mothers: Association with drinking water and time trends of inner exposures--Results of the Duisburg birth cohort and Bochum cohort studies.

Wilhelm M, Wittsiepe J, Völkel W, Fromme H, Kasper-Sonnenberg M.

Int J Hyg Environ Health. 2015 Oct;218(7):645-55. doi: 10.1016/j.ijheh.2015.07.001. Epub 2015 Jul 9.

PMID:
26212496
18.

Influence of the uncertainty in the validation of PBPK models: A case-study for PFOS and PFOA.

Fàbrega F, Nadal M, Schuhmacher M, Domingo JL, Kumar V.

Regul Toxicol Pharmacol. 2016 Jun;77:230-9. doi: 10.1016/j.yrtph.2016.03.009. Epub 2016 Mar 15.

PMID:
26993749
19.

Association of perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS) with uric acid among adults with elevated community exposure to PFOA.

Steenland K, Tinker S, Shankar A, Ducatman A.

Environ Health Perspect. 2010 Feb;118(2):229-33. doi: 10.1289/ehp.0900940.

20.

Renal clearance of perfluorooctane sulfonate and perfluorooctanoate in humans and their species-specific excretion.

Harada K, Inoue K, Morikawa A, Yoshinaga T, Saito N, Koizumi A.

Environ Res. 2005 Oct;99(2):253-61. Epub 2005 Jan 18.

PMID:
16194675

Supplemental Content

Support Center